Capital Advisory Group Advisory Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-200
Closed -$8K 540
2021
Q1
$8K Hold
200
﹤0.01% 403
2020
Q4
$7K Hold
200
﹤0.01% 400
2020
Q3
$8K Hold
200
﹤0.01% 338
2020
Q2
$7K Sell
200
-300
-60% -$10.8K ﹤0.01% 333
2020
Q1
$17K Buy
+500
New +$19.5K 0.02% 175
2019
Q4
Sell
-500
Closed -$20K 225
2019
Q3
$20K Sell
500
-200
-29% -$8.47K 0.01% 207
2019
Q2
$30K Hold
700
0.02% 185
2019
Q1
$27K Hold
700
0.02% 179
2018
Q4
$25K Hold
700
0.02% 177
2018
Q3
$27K Hold
700
0.02% 176
2018
Q2
$23K Buy
700
+200
+40% +$6.03K 0.02% 170
2018
Q1
$14K Buy
+500
New +$13.6K 0.01% 208

Other funds holding BSX

Capital Advisory Group Advisory Services's BSX Position: Q2 2021 in Review

Capital Advisory Group Advisory Services sold out of Boston Scientific (BSX) in Q2 2021, closing a stake of 200 shares — an estimated $8K sold.

Capital Advisory Group Advisory Services first reported a position in BSX in Q1 2018 and held it in 12 quarters. The position peaked at $30K in Q2 2019. 867 funds tracked by Wall St. Rank hold BSX as of Q2 2021.

  • Capital Advisory Group Advisory Services reported no remaining Boston Scientific position as of Q2 2021 after selling out during the quarter.
  • Capital Advisory Group Advisory Services sold 200 Boston Scientific shares in Q2 2021, an estimated $8K.
  • Capital Advisory Group Advisory Services first reported a position in Boston Scientific in Q1 2018 and held it in 12 quarters.
  • Capital Advisory Group Advisory Services's Boston Scientific position peaked at $30K in Q2 2019.
  • 867 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2021.

Based on Capital Advisory Group Advisory Services's 13F filing for Q2 2021, filed 12 Nov 2021.